This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kostner, K. M. Articles by Kostner, G. M. Search for Related Content PubMed PubMed Citation Articles by Kostner, K. M. Articles by Kostner, G. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:905.)
© 1996 American Heart Association, Inc.

Articles

Urinary Excretion of Apo(a) Fragments

Role in Apo(a) Catabolism

Karam M. Kostner; Gerald Maurer; Kurt Huber; Thomas Stefenelli; Hans Dieplinger; Ernst Steyrer; Gert M. Kostner

the Second Department of Medicine (K.M.K., G.M., K.H., T.S.), Division of Cardiology, University Hospital of Vienna; the Institute of Medical Biology and Human Genetics (H.D.), University of Innsbruck; and the Institute of Medical Biochemistry (E.S., G.M.K.), University of Graz, Austria.

Correspondence to Dr Karam Kostner, AKH Wien, Department of Cardiology, Währingergürtel 18-20, A-1090 Vienna, Austria.

Abstract

The biosynthesis and assembly of lipoprotein(a) [Lp(a)], a marker for atherosclerotic disease, appears to be well understood. However, information is lacking concerning the mode and site of Lp(a) catabolism. Apo(a) is reported to be excreted into the urine. To study the effect of this pathway on the overall catabolism of Lp(a), urinary apo(a) was characterized by immunoblotting. More than 10 distinct apo(a) bands with molecular masses between 30 and 160 kD were observed. Apo(a) fragments were not complexed to apoB. In more than 30 individuals the size of apo(a) bands was comparable irrespective of their apo(a) phenotype, although marked differences in the relative intensities of the bands were observed. Eight batches of 24-hour urine collections collected from one proband at 2-week intervals exhibited a significant correlation between creatinine and apo(a) concentrations as measured by DELFIA (r=.93; P<.01). In 193 healthy volunteers a highly significant correlation was found between urinary apo(a) concentrations normalized to creatinine levels and plasma Lp(a) values (=0.659; P<.0001). Of the total plasma apo(a), 0.073%, ie, 121 µg apo(a), was excreted in the form of apo(a) fragments in 24-hour urine samples from 12 healthy volunteers. We conclude that the catabolism of Lp(a) via excretion of apo(a) fragments accounts for <1% of the daily Lp(a) catabolism.

Key Words: kidney • urinary excretion • kringle IV

This article has been cited by other articles:

				S. M. Marcovina, M. L. Koschinsky, J. J. Albers, and S. Skarlatos Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions Clin. Chem., November 1, 2003; 49(11): 1785 - 1796. [Abstract] [Full Text] [PDF]

				E. Cauza, J. Kletzmaier, G. Bodlaj, A. Dunky, W. Herrmann, and K. Kostner Relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function Nephrol. Dial. Transplant., August 1, 2003; 18(8): 1568 - 1572. [Abstract] [Full Text] [PDF]

				E. Cauza, J. Kletzmaier, G. Bodlaj, A. Dunky, W. Herrmann, and K. Kostner Relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function Nephrol. Dial. Transplant., August 1, 2003; 18(88): 1568 - 1572. [Abstract] [Full Text]

				F. WAHN, V. DANIEL, F. KRONENBERG, G. OPELZ, D. V. MICHALK, and U. QUERFELD Impact of Apolipoprotein(a) Phenotypes on Long-Term Renal Transplant Survival J. Am. Soc. Nephrol., May 1, 2001; 12(5): 1052 - 1058. [Abstract] [Full Text]

				V. Schulter, P. Koolwijk, E. Peters, S. Frank, A. Hrzenjak, W. F. Graier, V. W. M. van Hinsbergh, and G. M. Kostner Impact of Apolipoprotein(a) on In Vitro Angiogenesis Arterioscler Thromb Vasc Biol, March 1, 2001; 21(3): 433 - 438. [Abstract] [Full Text] [PDF]

				V. Mooser, M. M. Berger, L. Tappy, C. Cayeux, S. M. Marcovina, R. Darioli, P. Nicod, and R. Chiolero Major Reduction in Plasma Lp(a) Levels During Sepsis and Burns Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1137 - 1142. [Abstract] [Full Text] [PDF]

				C. DOUCET, V. MOOSER, S. GONBERT, F. RAYMOND, J. CHAPMAN, C. JACOBS, and J. THILLET Lipoprotein(a) in the Nephrotic Syndrome: Molecular Analysis ofLipoprotein(a) and Apolipoprotein(a) Fragments in Plasma and Urine J. Am. Soc. Nephrol., March 1, 2000; 11(3): 507 - 513. [Abstract] [Full Text] [PDF]

				F. KRONENBERG, E. KUEN, E. RITZ, R. JUNKER, P. KÖNIG, G. KRAATZ, K. LHOTTA, J. F. E. MANN, G. A. MÜLLER, U. NEYER, et al. Lipoprotein(a) Serum Concentrations and Apolipoprotein(a) Phenotypes in Mild and Moderate Renal Failure J. Am. Soc. Nephrol., January 1, 2000; 11(1): 105 - 115. [Abstract] [Full Text]

				G. M. Kostner, A. Ibovnik, H. Holzer, and H. Grillhofer Preparation of a stable fresh frozen primary lipoprotein[a] (Lp[a]) standard J. Lipid Res., December 1, 1999; 40(12): 2255 - 2263. [Abstract] [Full Text] [PDF]

				V. Mooser, F. Tinguely, P. Fontana, V. Lenain, M. Vaglio, P. Ruchat, L. K. von Segesser, S. M. Marcovina, M. Markert, R. Darioli, et al. Effect of Cardiopulmonary Bypass and Heparin on Plasma Levels of Lp(a) and Apo(a) Fragments Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 1060 - 1065. [Abstract] [Full Text] [PDF]

				A. Niemeier, T. Willnow, H. Dieplinger, C. Jacobsen, N. Meyer, J. Hilpert, and U. Beisiegel Identification of Megalin/gp330 as a Receptor for Lipoprotein(a) In Vitro Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 552 - 561. [Abstract] [Full Text] [PDF]